Globus Medical Preps IPO, Sales Force Ramp Ahead Of Artificial Cervical Disc Approval
This article was originally published in The Gray Sheet
Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.
You may also be interested in...
Globus Medical goes public. Exact Sciences nets $57.8 million from stock sale for cancer test. Cleveland Heart gets $30 million for artificial heart development. More financings.
Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance
Drawing on 24 years as a legislator and another 16 years as a leading lobbyist for biopharma, Jim Greenwood sees an opportunity for industry to put drug pricing ‘behind us’ with a legislative compromise.